Abstract
The presence of subvisible particles (SVPs) in parenteral formulations of biologics is a major challenge in the development of therapeutic protein formulations. Distinction between proteinaceous and non-proteinaceous SVPs is vital in monitoring formulation stability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have